Tag: pharmaceuticals
-
Health Agency Funds Drug-Resistant Bacteria R&D
Biomedical Advanced Research and Development Authority, or BARDA, signed agreements worth $67 million to develop new treatments and diagnostics for urgent drug-resistant infections.
-
Clinical Trial Testing Live Bacteria as Acne Treatment
A clinical trial is recruiting participants to test a product with live skin bacteria made by biotechnology company AOBiome as a treatment for adult acne.
-
Teva Licenses Pain Relief Antibody for $1.25 Billion
Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals.
-
FDA Holding Opioid Overdose App Competition
The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose.
-
Drug Shown to Improve Cell Energy, Muscle Function
Results of a clinical trial show an experimental drug by Stealth BioTherapeutics boosts cellular energy and improves skeletal muscle functions of older adults.
-
Lung Tissue Grown in Lab from Stem Cells
Researchers in regenerative medicine at UCLA grew three-dimensional pieces of human lung tissue in lab cultures starting from stem cells.
-
Challenge Seeks Health Technology Start-Ups
A new competition is seeking start-up enterprises worldwide to pitch their ideas for solving health care issues with technology directly to life sciences industry leaders.
-
Stem Cells Aid Motor Functions in Spinal Cord Patients
First results from a clinical trial show stem cell treatments help restore some arm and hand functioning in patients with complete cervical spinal cord injury.
-
Computational Drug Discovery Company Launches
A new enterprise, Relay Therapeutics, is being formed for computer-driven discovery of new drugs based on the movements and interactions of protein molecules.
-
Synthetic Viruses in Gene Therapy Licensed for Production
Techniques from academic research for developing synthetic viruses to deliver gene therapies are being licensed for commercial production and distribution.